Table of Contents Author Guidelines Submit a Manuscript
Volume 2017, Article ID 7429697, 10 pages
Review Article

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies

1Center for Cancer and Blood Disorders, Children’s National Health System, 111 Michigan Ave NW, Washington, DC 20010, USA
2Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Room 6E450, Bethesda, MD 20892, USA
3Rare Tumors Initiative, OD, CCR, National Cancer Institute, 37 Convent Drive, Bethesda, MD 20814, USA
4University of Utah, 295 Chipeta Way, Salt Lake City, UT 84108, USA
5Center for Cancer Research, National Cancer Institute, 10 Center Drive, Room 2S235C, Building 10, Bethesda, MD 20892, USA
6National Cancer Institute, Pediatric Oncology Branch, 10 Center Drive, Room 1-3742, Building 10, Bethesda, MD 20892, USA

Correspondence should be addressed to AeRang Kim; gro.lanoitansnerdlihc@mikea

Received 6 February 2017; Accepted 3 April 2017; Published 16 May 2017

Academic Editor: Alexander Lazar

Copyright © 2017 AeRang Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

NF1 or sporadic MPNST cell lines from primary or metastatic human and mice tumors have been described in the literature to varying degrees and are listed in Supplemental Table 1.

  1. Supplementary Material